Recent studies have shown that, compared with tissue-resident Tregs in normal tissues, CCR8 is particularly high in tumor-resident Tregs in breast cancer, colorectal cancer and lung cancer patients [28]. This evidence concerns the gene CCR8 and colorectal cancer.